|
⚲
|
| Sally Mulligan | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001469309 |
| Sale | |
| Fund | |
| Phone | 61292565239 |
| Address | Level 40 Sydney, 2000 |
| Source | [EDGAR] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Michael Ihlein | |
| Brian Schwartz | |
| Anthony Froggatt | |
| Christopher Mayhew | |
| Paul Stephen | |
| Mary Doherty | |
| Graham Kraehe | |
| David Gosnell | |
| Sarah Kay |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
White Paul T
✚
|
0.0 | |
|
Oasis Land LTD
✚
|
0.0 | |
|
O DOWD Joseph P
✚
|
0.0 | |
|
Storiant, Inc.
✚
|
0.0 | |
|
Xiong Wenhui
✚
|
0.0 | |
|
Odyssey Alvarado Asset LLC
✚
|
0.0 | |
|
Ofir Yehezkel
✚
|
0.0 | |
|
Xomi, Inc.
✚
|
0.0 | |
|
OLY Fund I, a series of DVC, LP
✚
|
0.0 | |
|
Nobilis Therapeutics Inc
✚
|
0.0 |